Clinical trial
A Prospective Controlled Multi-Center Study on M2a Magnum Total Hip Arthroplasty
NCT01010763 is registered in ClinicalTrials.gov with Zimmer Biomet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Controlled Multi-Center Study on M2a Magnum Total Hip Arthroplasty
- Lead sponsor
- Zimmer Biomet
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2009
- Completion date
- April 28, 2017
- Enrollment
- 184 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
avascular necrosis, degenerative joint disease